Skip to content

CanCope: Digital Intervention for Coping With Cannabis Craving

CanCope: Digital Intervention for Coping With Cannabis Craving

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05328362
Enrollment
53
Registered
2022-04-14
Start date
2021-08-27
Completion date
2021-12-16
Last updated
2025-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis Use

Brief summary

The CanCope Study is a micro-randomized trial conducted to gather evidence about and compare the effectiveness of a momentary intervention to help young adults cope with cannabis cravings as they attempt to reduce their use.

Detailed description

The CanCope Study is designed to test the effectiveness of two distinct strategies (mindfulness and distraction) to cope with cannabis cravings in young adults (19 - 25 years) who are attempting to reduce their cannabis use. Cannabis use is determined using a single-item question about the number of days out of the past 30 days the individual used cannabis. Young adults who reported using cannabis \>10 out of the past 30 days, who were not pregnant or breastfeeding, and who were not currently in treatment for problems related to substance use were eligible to enroll in this four-week study. The CanCope intervention was delivered to participants through the MetricWire app, which was available for download on the participants' personal smartphones. Participants were asked to complete five ecological momentary assessments (EMA) per day, which asked questions related to cannabis use including one question about current level of craving on a scale of 0 - 10. If a participant reported a craving level \>4, a message was sent via the app encouraging the participant to try a mindfulness or distraction coping strategy, or the participant received a thank-you for completing the EMA which served as an attention control.

Interventions

BEHAVIORALCanCope

Messages prompted participants to use mindfulness-based or distraction-based coping strategies, or a thank-you message which served as an attention control. If participants reported elevated craving (4 or greater) prior to a decision point, they received either a coping strategy message or a control message. If participants reported craving levels of less than 4 they received a control message.

Sponsors

University of Michigan
CollaboratorOTHER
Trustees of Dartmouth College
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Micro-Randomized Trial (MRT)

Eligibility

Sex/Gender
ALL
Age
19 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Used cannabis at least 10 out of the past 30 days

Exclusion criteria

* Currently pregnant or breastfeeding * Currently in treatment for problems related to substance use

Design outcomes

Primary

MeasureTime frameDescription
Average Craving Level - Active vs. Control MessagesMinimum 2.8 hours after each decision point; Maximum 12.8 hours after each decision pointParticipants were asked to rate their level of cannabis craving on a scale of 0 - 10 five times per day where higher scores indicate more craving. Participants were considered available for randomization when craving \>=4 and they clicked the intervention message in the study app. To determine the effect of messaging on craving, we will calculate the average craving level for each EMA eligible for intervention and randomized to receive an active coping strategy message or a control message. It was pre-specified based on a priori power analyses for this small pilot study to combine the mindfulness-based coping strategies and distraction-based coping strategies interventions in the Active Message Row. Craving levels will be averaged across randomized observations. There were up to 140 decision points (5 EMAs per day x 28 days) per participant for the intervention period.

Countries

United States

Participant flow

Pre-assignment details

Participants consented to the study in the app prior to completing any eligibility screening measures. Participants who consented but then failed to complete screening or any EMA assessments were not enrolled. EMA completion was required to randomize individual decision points (completed EMAs) to an intervention in this study design. N=53 were enrolled based on these criteria.

Participants by arm

ArmCount
CanCope Intervention
The CanCope intervention was delivered through the MetricWire app which was available to each participant on their personal smartphone. The intervention included a push component which was responsive to a participant's level of craving (based on self-report assessed via EMA) and sent messages to each participant via the MetricWire app according to a decision rule. MetricWire randomized delivery of the push component with a probability of 0.33 for receiving a mindfulness coping strategy, 0.33 for receiving a distraction coping strategy, and 0.33 for receiving a thank-you message (attention control) at each decision point when participants were available for the intervention. CanCope: Messages prompted participants to use mindfulness-based or distraction-based coping strategies, or a thank-you message which served as an attention control. If participants reported elevated craving (4 or greater) prior to a decision point, they received either a coping strategy message or a control message. If participants reported craving levels of less than 4 they received a control message.
53
Total53

Baseline characteristics

CharacteristicCanCope Intervention
Age, Continuous22.04 years
STANDARD_DEVIATION 1.97
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
41 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
White
42 Participants
Region of Enrollment
United States
53 participants
Sex/Gender, Customized
Gender
Man
27 Participants
Sex/Gender, Customized
Gender
Nonbinary
6 Participants
Sex/Gender, Customized
Gender
Woman
20 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 53
other
Total, other adverse events
0 / 53
serious
Total, serious adverse events
0 / 53

Outcome results

Primary

Average Craving Level - Active vs. Control Messages

Participants were asked to rate their level of cannabis craving on a scale of 0 - 10 five times per day where higher scores indicate more craving. Participants were considered available for randomization when craving \>=4 and they clicked the intervention message in the study app. To determine the effect of messaging on craving, we will calculate the average craving level for each EMA eligible for intervention and randomized to receive an active coping strategy message or a control message. It was pre-specified based on a priori power analyses for this small pilot study to combine the mindfulness-based coping strategies and distraction-based coping strategies interventions in the Active Message Row. Craving levels will be averaged across randomized observations. There were up to 140 decision points (5 EMAs per day x 28 days) per participant for the intervention period.

Time frame: Minimum 2.8 hours after each decision point; Maximum 12.8 hours after each decision point

Population: Only participants who completed baseline measures and at least one ecological momentary assessment (EMA) are included in the analyses. Two participants who completed baseline measures did not complete any EMAs which were required for micro-randomization and are therefore not included in the analyses.

ArmMeasureGroupValue (MEAN)Dispersion
CanCope InterventionAverage Craving Level - Active vs. Control MessagesControl Message4.736 score on a scaleStandard Deviation 2.822
CanCope InterventionAverage Craving Level - Active vs. Control MessagesActive Message4.629 score on a scaleStandard Deviation 2.78

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026